Business · 07/10/2020Updated: 10/17/2026 · 1 min read
FDA Announces Fee Rates for Tropical Disease Priority Review Vouchers for Fiscal Year 2021
Summary
The US Food and Drug Administration (FDA) has set the fee rates for using a tropical disease priority review voucher for the 2021 fiscal year, as mandated by the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Food and Drug Administration Amendments Act of 2007 (FDAAA).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →